Does Rallies show Form 4 insider transactions for AGL?

Yes. Rallies tracks AGL insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is AGL research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AGL. It does not provide personalized investment advice.

AGL (agilon health, inc.) Stock Analysis - Insider Trades

agilon health, inc. (AGL) is a publicly traded Healthcare sector company. As of May 21, 2026, AGL trades at $80.01 with a market cap of $1.45B and a P/E ratio of 0.00. AGL moved -8.59% today. Year to date, AGL is +367.52%; over the trailing twelve months it is +30.55%. Its 52-week range spans $7.48 to $152.00. Analyst consensus is neutral with an average price target of $37.46. Rallies surfaces AGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading AGL stock inside the company?

Recent AGL insider activity includes Shaker Benjamin bought 500.00K, Wulf John William bought 81.00K, McLoughlin Karen bought 25.00K, Battaglia Silvana bought 25.06K, and MCKENZIE DIANA bought 7.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

AGL Key Metrics

Key financial metrics for AGL
Metric	Value
Price	$80.01
Market Cap	$1.45B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.11%
52-Week High	$152.00
52-Week Low	$7.48
Volume	177
Avg Volume	0
Revenue (TTM)	$5.82B
Net Income	$-354.54M
Gross Margin	0.00%

Recent AGL Insider Trades

Shaker Benjamin bought 500.00K (~$301.05K) on Mar 2, 2026.
Wulf John William bought 81.00K (~$50.94K) on Nov 12, 2025.
McLoughlin Karen bought 25.00K (~$55.08K) on Dec 13, 2024.
Battaglia Silvana bought 25.06K (~$50.27K) on Dec 11, 2024.
MCKENZIE DIANA bought 7.50K (~$16.49K) on Dec 9, 2024.

Latest AGL News

Agilon Health Shares Surge 117.76% to $60.65 on Upgraded 2026 Guidance — May 7, 2026
Agilon Health Q1 EPS Beats Estimates, Raises Full-Year Revenue Guidance to $5.68–5.81B — May 6, 2026
AGL Energy Cuts Battery Project Costs by 50% on New South Wales Builds — Apr 20, 2026
agilon health to Implement 1-for-25 Reverse Split on March 30 — Mar 18, 2026
Agilon Health Shares Soar 23% on CMO’s $301K Stock Buy — Mar 4, 2026

AGL Analyst Consensus

15 analysts cover AGL: 0 strong buy, 4 buy, 8 hold, 3 sell, 0 strong sell. Consensus rating is neutral. Average price target: $37.46.

Common questions about AGL

Who is trading AGL stock inside the company?: Recent AGL insider activity includes Shaker Benjamin bought 500.00K, Wulf John William bought 81.00K, McLoughlin Karen bought 25.00K, Battaglia Silvana bought 25.06K, and MCKENZIE DIANA bought 7.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for AGL?: Yes. Rallies tracks AGL insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is AGL research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AGL. It does not provide personalized investment advice.